middle.news
How Is IMEXHS Scaling SaaS Amid Margin Pressures and Regulatory Risks?
10:01am on Tuesday 2nd of September, 2025 AEST
•
Healthcare
Read Story
How Is IMEXHS Scaling SaaS Amid Margin Pressures and Regulatory Risks?
10:01am on Tuesday 2nd of September, 2025 AEST
Key Points
Sales revenue rose 4% to $13.7 million in 1H FY25
Annual recurring revenue (ARR) increased 11% to $32.8 million
Software ARR surged 20% but underlying EBITDA declined
Radiology services showed modest revenue growth and improved EBITDA
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imexhs (ASX:IME)
OPEN ARTICLE